With or without a gold standard

Epidemiology

Volumn 16, Issue 5, 2005, Pages 595-597

  Pfeiffer, Ruth M ^a   Castle, Philip E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AREA UNDER THE CURVE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COLPOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EXPOSURE; HUMAN; NONHUMAN; NOTE; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STANDARD; STATISTICAL ANALYSIS; UTERINE CERVIX TUMOR; WART VIRUS;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HEARING DISORDERS; HUMANS; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PANCREATIC NEOPLASMS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 24144501800     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ede.0000173328.31497.ec     Document Type: Note

References (12)

1. Pepe MS, Longton G. Standardizing markers to evaluate and compare their performances. Epidemiology. 2005;16:598-603.
2. Hagdu A, Dendukuri N, Hilden J. Evaluation of nucleic acid amplification tests in the absence of a perfect gold-standard test: a review of the statistical and epidemiologic issues. Epidemiology. 2005;16:604-612.
3. van Doornum GJ, Buimer M, Prins M, et al. Detection of chlamydia trachomatis infection in urine samples from men and women by ligase chain reaction. J Clin Microbiol. 1995;33:2042-2047.
4. Hui SL, Zhou XH. Evaluation of diagnostic tests without gold standards. Stat Methods Med Res. 1998;7:354-370.
5. Herrero R, Schiffman MH, Bratti C, et al. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica. 1997;1:362-375.
6. Castle PE, Schiffman M, Gravitt PE, et al. Comparisons of HPV DNA Detection by MY09/11 PCR Methods. J Med Virol. 2002;68:417-423.
7. Herrero R, Castle PE, Schiffman M, et al. Epidemiology of type-specific HPV infection in Guanacaste. J Infect Dis. 2005;191:1796-1807.
8. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527.
9. Albert PS, Dodd LE. A cautionary note on the robustness of latent class models for estimating diagnostic error without a gold standard. Biometrics. 2004;60:427-435.
10. Nagelkerke NJ, Fidler V, Buwalda M. Instrumental variables in the evaluation of diagnostic test procedures when the true disease state is unknown. Stat Med. 1988;7:739-744.
11. Guido R, Schiffman M, Solomon D, et al. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol. 2003;188:1401-1405.
12. Schiffman M, Wheeler CM, Dasgupta A, et al. A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal Pap smears. Accepted to Am J Clinic Pathol 2005; in press.